0001493152-23-031869.txt : 20230906 0001493152-23-031869.hdr.sgml : 20230906 20230906171717 ACCESSION NUMBER: 0001493152-23-031869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230718 FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stockwell Lynn CENTRAL INDEX KEY: 0001927032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41395 FILM NUMBER: 231240131 MAIL ADDRESS: STREET 1: 401 EAST LAS OLAS BLVD. STREET 2: SUITE 1400 CITY: FT. LAUDERDALE STATE: FL ZIP: 33301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bright Green Corp CENTRAL INDEX KEY: 0001886799 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 401 EAST LAS OLAS BLVD. STREET 2: SUITE 1400 CITY: FT. LAUDERDALE STATE: FL ZIP: 33301 BUSINESS PHONE: (201)370-1140 MAIL ADDRESS: STREET 1: 401 EAST LAS OLAS BLVD. STREET 2: SUITE 1400 CITY: FT. LAUDERDALE STATE: FL ZIP: 33301 4 1 ownership.xml X0508 4 2023-07-18 0 0001886799 Bright Green Corp BGXX 0001927032 Stockwell Lynn 1033 GEORGE HANOSH BOULEVARD GRANTS NM 87020 1 0 1 0 0 Common Stock 2023-07-18 4 G 0 2500000 0.00 A 67583475 D Common Stock 2023-08-22 4 G 0 977777 0.00 D 66605698 D Common Stock 2023-08-31 4 S 0 250000 0.4667 D 66355698 D Common Stock 2023-09-01 4 J 0 2827960 1.15 A 69183658 D Warrant (right to buy) 3.00 2023-09-01 4 J 0 2827960 0.13 A 2023-09-01 Common Stock 2827960 2827960 D These transactions involved a bona fide gift of securities by the Reporting Person's child to the Reporting Person and subsequent bona fide gift of securities by the Reporting Person to family members of the Report Person. No consideration was paid by or to the Reporting Person in connection with these transactions. This transaction involved an open market sale of the Issuer's Common Stock. Reflects the weighted average price of 250,000 shares of common stock of the Issuer sold by the Reporting Person in multiple transactions on August 31, 2023, with sales prices ranging from $0.4549 to $0.4823 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. In connection with an unsecured line of credit in the form of a note (the "Note") between the Issuer and the Reporting Person, on September 1, 2023, the Issuer and the Reporting Person entered into an agreement pursuant to which the Issuer issued to the Reporting Person (i) 2,827,960 shares (the "Shares") of the Issuer's common stock at a conversion price of $1.15 per share, and (ii) warrants (the "Warrants") to purchase up to 2,827,960 shares of the Issuer's common stock at a conversion price of $0.13 per warrant. The issuance of the Shares and the Warrants was made to settle all amounts of principal interests and other costs under the Note as of August 31, 2023 (the "Repayment Obligation"). The Warrants are exercisable immediately upon issuance at an exercise price of $3.00 per share, and shall expire on the earlier of (i) the date that is 45 days after the closing price of the Common Stock on the Nasdaq Capital Market equals or exceeds $3.00 per share, and (ii) August 31, 2024. /s/ Lynn Stockwell 2023-09-06